Literature DB >> 1874938

Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow.

A D Baron1, M Laakso, G Brechtel, S V Edelman.   

Abstract

To define the kinetic mechanisms of insulin resistance (IR) in insulin-dependent diabetes (IDDM), we studied seven control (C) and five IDDM (glycohemoglobin, 14 +/- 2+) men matched for age (36 +/- 2 vs. 37 +/- 3 yr), lean body mass (59 +/- 2 vs. 58 +/- 3 kg), and leg volume (mean +/- SEM, 10.4 +/- 0.3 vs. 9.8 +/- 0.5 L). Maximal capacity (Vmax) and affinity (Km) for glucose uptake in whole body (WBGU) and leg skeletal muscle (LGU) were measured during a 120 mU/m2.min insulin infusion, and blood glucose was clamped at about 4, 7, 12, and 21 mmol/L. LGU = femoral arterio-venous glucose difference (FAVGD) X leg blood flow (LBF). Compared to C, IDDMs had about 35% lower rates of WBGU at all glucose levels (P less than 0.01). The FAVGD (millimoles per L) in C vs. IDDM was 1.23 +/- 0.05 vs. 1.06 +/- 0.09, 2.44 +/- 0.11 vs. 2.24 +/- 0.16, 2.91 +/- 0.18 vs. 2.91 +/- 0.30, and 3.27 +/- 0.12 vs. 3.35 +/- 0.4 (P = NS at each glucose). LBF (decaliters per min) was reduced in IDDM vs. C [2.8 +/- 0.5 vs. 4.3 +/- 0.4 (P less than 0.05), 3.1 +/- 0.4 vs. 5.1 +/- 0.7 (P less than 0.05), 2.7 +/- 0.2 vs. 6.3 +/- 0.8 (P less than 0.01), and 3.1 +/- 0.7 vs. 6.5 +/- 0.8 (P less than 0.01) at each glucose level]. Kinetic analysis revealed that 1) the Vmax for WBGU and LGU were reduced in IDDM vs. C (P less than 0.05), and 2) the Vmax for skeletal muscle glucose extraction (FAVGD) was identical in C and IDDM (3.6 mmol/L). The Km values for WBGU, LGU, and glucose extraction were not different in C and IDDM (approximately 6 mmol/L). Thus, in IDDM 1) decreased glucose uptake is due to reduced skeletal muscle glucose uptake; 2) muscle glucose extraction is normal, but blood flow is reduced; and thus, 3) in IDDM, IR is due to reduced glucose and insulin delivery (blood flow) to skeletal muscle. This represents a novel mechanism for in vivo IR.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874938     DOI: 10.1210/jcem-73-3-637

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  49 in total

1.  Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus.

Authors:  A Chan; E J Barrett; S M Anderson; B P Kovatchev; M D Breton
Journal:  Diabetologia       Date:  2011-12-14       Impact factor: 10.122

2.  Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

Authors:  T Utriainen; P Nuutila; T Takala; P Vicini; U Ruotsalainen; T Rönnemaa; T Tolvanen; M Raitakari; M Haaparanta; O Kirvelä; C Cobelli; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 3.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

Review 4.  New insights into insulin action and resistance in the vasculature.

Authors:  Camila Manrique; Guido Lastra; James R Sowers
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

Review 5.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

6.  Skeletal muscle microvascular insulin resistance in type 2 diabetes is not improved by eight weeks of regular walking.

Authors:  Lauren K Park; Elizabeth J Parks; Ryan J Pettit-Mee; Makenzie L Woodford; Thaysa Ghiarone; James A Smith; Allan R K Sales; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla
Journal:  J Appl Physiol (1985)       Date:  2020-07-02

7.  Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.

Authors:  O Selberg; W Burchert; J vd Hoff; G J Meyer; H Hundeshagen; E Radoch; H J Balks; M J Müller
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men.

Authors:  A D Baron; G Brechtel; A Johnson; N Fineberg; D P Henry; H O Steinberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 9.  Skeletal muscle insulin resistance in endocrine disease.

Authors:  Melpomeni Peppa; Chrysi Koliaki; Panagiotis Nikolopoulos; Sotirios A Raptis
Journal:  J Biomed Biotechnol       Date:  2010-03-15

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.